N@N

Market Maker Surveillance Report. LOCM, ZHNE, CVBK, HAUP, ANX, XOMA, Losing Stocks With Lowest Price Friction For Friday, Janu

^{Published on 2011-01-07 17:50:56 - WOPRAI}
 

January 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 2763 companies with "abnormal" market making, 2210 companies with positive Friction Factors and 2854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. LOCAL.COM CORP (NASDAQ:LOCM), ZHONE TECHNOLOGIES INC (NASDAQ:ZHNE), CENTRAL VIRGINIA BANKSHARES (NASDAQ:CVBK), HAUPPAUGE DIGITAL INC (NASDAQ:HAUP), ADVENTRX PHARMACEUTICALS INC (AMEX:ANX), XOMA LTD (NASDAQ:XOMA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     LOCM       $-1.700      -24.54%      2,815,711       44.78%       3,457,160       54.98%       -641,449        -3,773  
     ZHNE       $-0.450      -14.85%      367,336         42.76%       490,277         57.07%       -122,941        -2,732  
     CVBK       $-0.340      -14.78%      27,869          45.77%       32,514          53.40%       -4,645          -137    
     HAUP       $-0.540      -14.79%      1,254,851       44.11%       1,548,494       54.43%       -293,643        -5,438  
     ANX        $-0.420      -14.33%      1,767,977       47.62%       1,819,600       49.01%       -51,623         -1,229  
     XOMA       $-0.950      -14.01%      6,726,714       48.26%       7,190,425       51.59%       -463,711        -4,881  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows XOMA with a dollar loss Friday of $-0.95000 and a Friction Factor of -4,881 shares. That means that it only took 4,881 more shares of selling than buying to move XOMA lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

LOCAL.COM CORP (NASDAQ:LOCM) - Local.com Corporation provides local search services on the Internet. It operates Local.com, a local business directory site that provides information on approximately 14 million local businesses. The company also provides local search services on its local syndication network of regional media sites for which it offers business directories and associated services, as well as provides sales and advertiser services. The company offers proprietary search results using its patented technologies, as well as monetizes those search results by placing sponsored listings on the search results page. Its sponsored listings comprise subscription, cost-per-click, cost-per-call, and display ads from its own direct advertisers and third-party advertiser sources. The company was formerly known as Interchange Corporation and changed its name to Local.com Corporation in November 2006. Local.com Corporation was founded in 1999 and is based in Irvine, California.

ZHONE TECHNOLOGIES INC (NASDAQ:ZHNE) - Zhone Technologies, Inc., together with its subsidiaries, designs, develops, and manufactures communications network equipment for telecommunications, wireless, and cable operators worldwide. It offers single line multi-service (SLMS) architecture, which provides support for voice over Internet protocol (VoIP) and IP entertainment by integrating access, transport, customer premises equipment, and management functions in a standards-based system. Its SLMS products include broadband aggregation and service products that are deployed in central offices, remote offices, points of presence, curbsides, data and co-location centers, and large enterprises to aggregate, concentrate, and optimize communications traffic from copper and fiber networks; customer premise equipment, which offers solutions for combining analog voice and data services to the subscribers premises over a single platform; and Zhone Management System that provides optional software tools to manage aggregation and customer premises network hardware. These products deliver voice, data, and video interface connectivity for broadcast and subscription television, Internet routers, and telephony equipment. The company also offers products that are deployed by service providers to support various voice and data services; and provides technical support, product repair, and education and support services. Zhone Technologies, Inc. sells its products to network service providers that offer voice, data, and video services to businesses, governments, utilities, and residential consumers, as well as telecommunications carriers. The company offers its products and services through channel partners, which include distributors, resellers, system integrators, and service providers. Zhone Technologies, Inc. was founded in 1999 and is headquartered in Oakland, California.

CENTRAL VIRGINIA BANKSHARES (NASDAQ:CVBK) - Central Virginia Bankshares, Inc. operates as the bank holding company for Central Virginia Bank, which provides community and commercial banking services to individuals and small to medium sized businesses. Its deposit products include checking accounts, savings deposits, interest bearing demand deposits, non-interest bearing demand deposits, money market accounts, certificates of deposits, and other time deposits. The companys loan portfolio comprises residential mortgage, commercial mortgage, real estate construction, and commercial business loans, as well as consumer loans, such as automobile loans, home equity lines of credit, and credit cards. It also provides Internet banking, telephone banking, debit cards, and other ancillary services, such as the sale of non-deposit investment products. In addition, the company offers ATMs, travelers checks, safe deposit boxes, deposit transfer, notary public, escrow, drive-in facilities, and other customary banking services. As of December 31, 2009, it operated seven branches in Powhatan, Chesterfield, Henrico, and Cumberland counties of Virginia. The company was founded in 1972 and is headquartered in Powhatan, Virginia.

HAUPPAUGE DIGITAL INC (NASDAQ:HAUP) - Hauppauge Digital Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of analog and digital television (TV) tuner products for the personal computer (PC) market. The companys analog, digital, and other types of TV tuners allow PC users to watch television on a PC screen in a resizable window; enable the recording of TV shows to a PCs hard disk; digital video editing; video conferencing; and the display of digital media stored on a computer to a TV set via a home network. It also provides PCTV products, which allow Windows or Macintosh users to view television programming on their computers. In addition, the company offers other non-TV tuner products, including MediaMVP, a digital media device that enables a user to watch and listen to PC-based videos, music, and pictures on a TV set through a home network; ImpactVCB Video Capture Board, a PCI board for high performance access to digitized video; and Wing software, which enable the user to record TV shows on a personal computer for playback on the Sony Playstation Portable, Apple iPod, and other portable video players. Further, it provides WinTV-CI common interface module that allows the user to watch popular pay TV channels, such as movies and sporting events; and Xfones wireless headphones for PCs and Macs. Hauppauge Digital Inc. sells its products primarily through retailers, PC manufacturers, and distributors in the United States, Europe, and Asia. The company was founded in 1994 and is headquartered in Hauppauge, New York.

ADVENTRX PHARMACEUTICALS INC (AMEX:ANX) - ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates include ANX-530, an emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, as well as to treat advanced or metastatic breast cancer; and ANX-514, an emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company was founded in 1995 is headquartered in San Diego, California.

XOMA LTD (NASDAQ:XOMA) - XOMA Ltd., incorporated in 1981, is a biopharmaceutical company in the field of therapeutic antibody discovery and development. The Company has a royalty interest in one approved therapeutic antibody, RAPTIVA, which is marketed in the United States, Europe and elsewhere, for the treatment of moderate-to-severe plaque psoriasis. XOMA also has a future royalty interest in additional therapeutic antibody product candidates being developed by others as a result of licensing its technologies. XOMA's pipeline includes both products and collaborative programs at various stages of preclinical and clinical development primarily directed toward treatments for cancer and immune disorders. In addition to supporting its product pipeline, the Company uses its infrastructure to provide process development and manufacturing services on a fee-for-service basis.

RAPTIVA (Efalizumab)

The Company markets RAPTIVA under an agreement with Genentech, Inc. as a result of a prior collaborative product development program. RAPTIVA is a humanized therapeutic monoclonal antibody developed to treat immune system disorders. RAPTIVA can be self-administered by patients as a single, once-weekly subcutaneous injection. In 2005, Serono had launched RAPTIVA in over 40 countries worldwide.

RAPTIVA competes with Enbrel from Amgen Inc. and its partner Wyeth Pharmaceuticals; Amevive from Biogen Idec Inc.; BG-12 from Biogen Idec Inc. and Fumapharm AG; Remicade from Centocor, Inc. Humira from Abbott Laboratories, and ISA247 from Isotechnika, Inc.

CHIR-12.12

CHIR-12.12, which is being developed by the Company in collaboration with Chiron Corporation, is an anti-CD40 antagonist antibody intended as a treatment for B-cell malignancies. In April 2005, XOMA announced the initiation of Phase I study for patients with advance chronic lymphocytic leukemia (CLL). Then in October 2005, the Company initiated a second Phase I study for patients with multiple myeloma (MM).

NEUPREX (opebacan/rBPI21)

NEUPREX (opebacan/rBPI21) is an injectable formulation of rBPI21, a modified recombinant fragment of human bactericidal/permeability-increasing protein (BPI). BPI is a human host-defense protein made by a type of white blood cell that is involved in the body's defenses against microbial infection. In October of 2003, in conjunction with Children's Medical Center Dallas, the Company announced the initiation of an open-label, single center, dose escalation, investigator-sponsored, Phase I/II clinical trial of NEUPREX in pediatric patients with congenital heart abnormalities requiring open heart surgery associated with cardiopulmonary bypass.

XMA005.2

XMA005.2 is a Human Engineered monoclonal antibody with a high-affinity and potent inhibitory activity against its inflammatory target. This high potency means that it may be suitable for use as a monthly-dose injectable therapeutic. XOMA is evaluating XMA005.2 in preclinical studies targeting multiple indications, including osteoarthritis and rheumatoid arthritis, where less frequent dosing could be a significant marketing advantage.

Anti-gastrin Mab

In September of 2004, XOMA announced a worldwide collaboration with Aphton Corporation to develop treatments for gastrointestinal (GI) and other gastrin-sensitive cancers using anti-gastrin monoclonal antibodies. Gastrin has been shown to be involved in the progression of colorectal, stomach, liver and pancreatic cancers and inhibiting gastrin may inhibit such growth.

Metabolic Disease Target

The Company is co-developing Metabolic Disease Target with Lexicon Genetics. Metabolic Disease Target is a secreted protein involved in metabolic functions such as insulin sensitivity and weight gain that was identified through Lexicon's Knockout Technology. Antibodies to this target may be developed to treat Type II diabetes, obesity and other metabolic diseases.

MLN2222

MLN2222 (also known as CAB2) is being developed by XOMA in partnership with Millennium Pharmaceuticals, Inc. MLN2222 is a complement inhibitor for coronary artery bypass graft surgery tar

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net